The lawsuit was initially rejected by the Supreme Court before it was revived by Republican attorneys general in three states.

Reproductive-rights advocates are pushing back against the review of the abortion medication mifepristone ordered by Health ...

Kennedy, Jr., announced that he has directed the Food and Drug Administration (FDA) to undertake a review of its regulations ...

It’s really important that we protect ... safe access to medication abortion no matter where people live — Virginia is ...

The FDA has been tasked with re-evaluating the safety of mifepristone after a flawed report claimed it has a high rate of ...

The U.S. Food and Drug Administration is reviewing the regulation and labeling of the abortion pill mifepristone following ...

It's stance against a lawsuit challenging mifepristone puts it on the same footing as the Biden era, which backed the pill's ...

the drug’s warning label should be changed. The EPPC and its allies are hoping that at a minimum, the FDA will reinstate restrictions requiring that mifepristone be dispensed in person.

A new study analysing over 800,000 medical abortion cases has raised questions about the safety profile of mifepristone, a drug commonly used to terminate early pregnancies.

Gov. Gavin Newsom attends a watch party for Proposition 1, which would add rights for abortion and contraception to the California constitution, on Tuesday, Nov. 8, 2022 at the Citizen Hotel in ...

Kennedy Jr. Kennedy directed the Food and Drug Administration (FDA ... the drug to justify going against the existing science on mifepristone. They say the “new data” Kennedy mentioned ...

Health and Human Services Secretary Robert F. Kennedy Jr. has tasked the Food and Drug Administration with conducting a safety review of mifepristone, a pill used in most U.S. abortions.